Senior Scientist
Merck Life Science KGaA, Germany
Alana Gouveia is a Senior Scientist and PhD candidate at Merck KGaA, Darmstadt, Germany, in collaboration with Heidelberg University, where her research focuses on liposomal formulations for oral peptide delivery, with emphasis on GLP-1 analogs. She holds a B.Sc. and M.Sc. in Biology from the Technical University of Darmstadt, where she specialized in synthetic biology. Building on her academic background, she gained broad industry experience across food technology and pharmaceutical sectors, deepening her expertise in protein formulation — spanning plasma proteins, monoclonal antibodies, viscosity reduction, and stability of concentrated protein formulations. Prior to her PhD, she held scientist roles in Liquid Formulation R&D and excipient screening for protein formulations at Merck Life Science.